Newsletters & Blogs

NEW JERSEY LOVES ITS LIFE SCIENCES INNOVATORS

Posted by Philip P. Crowley | May 16, 2023 | 0 Comments

The State of New Jersey has an affinity for life sciences innovators. That's the message of last week's meeting sponsored by the NJ Economic Development Agency (“NJEDA”) at the Hackensack Meridian Health System Center for Discovery and Innovation in Nutley, NJ.  The meeting was headlined by Judit...

Continue Reading

WATCH OUT! AI IS COMING!

Posted by Philip P. Crowley | May 12, 2023 | 0 Comments

Watch out! Artificial intelligence (“AI”) is coming!  AI is coming to healthcare and drug discovery! Oops!! It's already here!! Google's DeepMind project is an AI research organization that has been involved in several groundbreaking projects in recent years. One of the areas where the technology...

Continue Reading

EDUCATION ON CENTER STAGE

Posted by Philip P. Crowley | May 12, 2023 | 0 Comments

Hope Through Education's Spring Gala was a great success. Nearly 300 people attended the event last week at the lovely Hamilton Farm Golf Club in Peapack-Gladstone, NJ.  Hope Through Education is a 501(c)(3) qualified charity focused on providing scholarships to families seeking to send their chi...

Continue Reading

WE ARE THE CHAMPIONS!!!

Posted by Philip P. Crowley | May 04, 2023 | 0 Comments

I am so proud of the Men's Volleyball Team at my alma mater, Stevens Institute of Technology (https://stevens.edu ).  They've just won the National Collegiate Athletic Association Division III (“D3”) championship.  Why is that significant? D3 schools are those universities and colleges that do no...

Continue Reading

NEW HOPE FOR PARKINSON’S DISEASE SUFFERERS

Posted by Philip P. Crowley | May 04, 2023 | 0 Comments

This week boasted announcement of a monumental achievement in the fight against Parkinson's disease. Parkinson's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. It is caused by the degeneration of dopamine-producing neurons in the brain, leading to t...

Continue Reading

CRITICAL POINT: Putting Together a Winning Team

Posted by Philip P. Crowley | Feb 22, 2023 | 0 Comments

Valuation of life sciences companies has been battered and the IPO window has closed, for now. But there are still plenty of strategic partners looking for promising new technology and life sciences companies to fill their pipelines. If you want to be one of them, having the right team put togeth...

Continue Reading

5 Startup Equity Mistakes and How to Avoid Them

Posted by Philip P. Crowley | Oct 19, 2022 | 0 Comments

Keeping to the fundamentals can be tough. As an overtasked and overwhelmed startup founder, it's tempting to look for DIY stop-gap solutions for equity issues with a mantra of “we can deal with this later.” It's like going after that vending machine Snickers bar (or two!!) when your stomach is gr...

Continue Reading

The Hidden Risks of Nondisclosure Agreements

Posted by Philip P. Crowley | Feb 09, 2022 | 0 Comments

What Life Sciences and Technology Startups Need to Know “The brands that innovate best do so with an exceptional embrace of collaboration.” ~Stephen Nowak Innovation rarely happens in a silo. But collaboration can also be a double-edged sword. Working with potential investors, creditors, clients,...

Continue Reading

6 Risks Hiding Inside Your Contracts

Posted by Philip P. Crowley | Jul 28, 2021 | 0 Comments

Are you overlooking areas of risk that may be lurking in the contracts you have entered into? Below are 6 commonly missed issues. 1. FAILURE TO OBTAIN A CONTRACT IN WRITING Lack of a written contract can lead to misunderstandings about what was agreed to – which can ultimately lead to litigation....

Continue Reading

Patents For Humanity Program Improvement Act – Acquisition And Sale Of “Acceleration Certificates” By Small Biotech Companies

Posted by Philip P. Crowley | Mar 09, 2021 | 0 Comments

Patents For Humanity Program Improvement Act The Patents for Humanity Program Improvement Act, H.R. 7259, was introduced on June 18th, 2020 and became law on January 5th, 2021. It was a bill that had bipartisan support to improve the United States Patent and Trademark Office's Patents for Humanit...

Continue Reading

The Benefits Of Orphan Drug Designation

Posted by Philip P. Crowley | Jan 25, 2021 | 0 Comments

According to the National Institutes of Health (NIH), there are over 7,000 diseases classified as rare, affecting an estimated 25-30 million Americans. These diseases range from genetic disorders to infections, cancers, or auto-immune diseases. These diseases can be chronic, progressive, and in t...

Continue Reading

Conducting Clinical Trials During the Pandemic

Posted by Philip P. Crowley | Sep 14, 2020 | 0 Comments

The COVID-19 pandemic has disrupted just about every national and global industry, and drug companies are certainly no exception. One of the primary concerns for the pharmaceutical industry is the impact on clinical trials of drugs, medical devices, and biological products. These trials are an ...

Continue Reading

  • 3 of 8